Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500115125) titled 'Comparison of survival outcomes between neoadjuvant and adjuvant therapy in patients with T1c, lymph node-negative, and hormone receptor-negative breast cancer: a study based on the SEER database and a Chinese cohort' on Dec. 23, 2025.
Study Type: Observational study
Study Design:
Sequential
Primary Sponsor: West China Hospital of Sichuan University
Condition:
Breast cancer
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2025-12-31
Target Sample Size: Case series :400;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=298170
Pu...